The ADHD Study Changing Psychiatry: Theory into Clinical Practice | Episode 88 with Towny Robinson

Towny Robinson is the CEO of JayMac Pharmaceuticals and an expert in methylation, genetics, and psychiatric disorders. We talk with Towny about a newly published ADHD study involving Enlyte, a nutritional supplement designed to support methylation pathways in children with ADHD. Together, we break down what methylation is, how genetic mutations can impact brain chemistry, and why these pathways may play a major role in ADHD, emotional dysregulation, autism, anxiety, and other mental health conditions.We also dive into the results of the 90-day study, which followed 42 children diagnosed with ADHD and found major improvements in attention, behavior, emotional regulation, and academic performance after taking Enlyte. Throughout the conversation, we discuss real patient success stories, the connection between inflammation and psychiatric symptoms, and how early intervention may help improve long-term mental health outcomes for children and families.To read the full ADHD study discussed in this episode, click here: https://www.enlyterx.com/trialsIf you’re interested in learning more about Towny’s work, you can visit EnLyte's website, https://www.enlyterx.com/ , for additional information and resources.Join Dr. Lauren LaRose, psychiatrist and mom of three, as she brings on experts in mental health, physical health and education and explores ideas outside the traditional medical model. The Little Brain Campaign aims to make issues kids and caregivers face easier to understand, while always keeping in mind that we need to look beyond the usual answers to find what really works.Follow The Little Brain CampaignInstagram: https://www.instagram.com/littlebraincampaign